Remote Patient Monitoring and Chronic Care Management for Patients with Diabetes opens the door to achieving Remission.
March 27, 2023 – GenieMD, Inc (“GenieMD”), a cloud-based, virtual care platform inclusive of Telehealth, Remote Patient Monitoring (RPM) and Chronic Care Management (CCM) and Redicare Control DTx (“Redicare”), a Digital Therapeutic that treats Chronic conditions such as High Blood Pressure, Pre-Diabetes, Type 2 Diabetes, High Cholesterol, Polycystic Ovary Syndrome (PCOS), Obesity and Overweight conditions.
Chronic diseases are the leading causes of death in the U,S, and they’re on the rise. According to the US Center for Disease Control (CDC), one in three adults in the U.S. has prediabetes (that’s about 96 million Americans. As well, 37.3 million Americans, about 1 in 10, have diabetes – 90%-95% of them have type 2 diabetes. As one of the most prevalent chronic conditions in healthcare, diabetes care cost $327 billion in 2017. Seventy-two percent of diabetes treatment costs ($237 billion) were related to direct healthcare expenses. RediCare ControlDTx helps people bring their Type 2 Diabetes under control quickly. In as little as 16 weeks you can see very significant HbA1c reductions of 13-15% which can bring many people with Type 2 Diabetes into remission, enabling reductions or elimination of mediations. Coupling Redicare’s ControlDTx with GenieMD’s virtual care services advances the patients journey along the care continuum to wellness.
“By bundling the differentiated digital therapeutic from Redicare and GenieMD’s virtual care services, we can bridge the gap between patients and healthcare providers, providing personalized and cost-effective care to those who need it most.” said Dr. Soheil Saadat, Founder and CEO GenieMD, “This innovative approach not only improves patient outcomes but also empowers patients to take an active role in managing their health.” Said Dr Niall Colwell, Cardiologist, and Redcare’s ControlDtx Chief Clinical Advisor.
About Redicare
RediCare is an award-winning digital therapeutics firm. With our core product ControlDTx, patients are transforming their health across the spectrum of cardio metabolic health. They are experiencing clinically significant reductions in Weight, HbA1c, Blood Pressure and improved Lipid profiles and PCOS remission. Many Type 2 Diabetic patients have reduced and eliminated their diabetes medications.
RediCare ControlDTx is creating a new normal in digital therapeutics for treating cardiometabolic diseases. We are defining a new way to treat diseases like Type 2 diabetes and heart disease by targeting the root cause, not just the effects, using digital therapeutics to deliver personalized clinically validated lifestyle therapy, which is a Class I indication in the management of chronic disease.
RediCare partners with primary care practices in the UK, Canada and Ireland and serves over 200 corporate clients with chronic disease screening and treatment services. For more information, please visit us at www.controldtx.com
About GenieMD
GenieMD is an award-winning, global provider of virtual care solutions, inclusive of: Telehealth, Remote Patient Monitoring (RPM), Remote Therapeutic Monitoring (RTM), and Chronic Care Management (CCM) coupled with access to medical experts on a 24/7 basis. GenieMD offers customized, white-labeled virtual care solutions to hospitals, health systems, large group practices, commercial insurance carriers, schools, and self-insured employers. GenieMD clients are based throughout the United States and the world. Maximizing the power of cloud computing, big data, artificial intelligence, and mobile technologies. GenieMD is transforming healthcare by providing a seamless and continuous care model to patients when they need it the most.
GenieMD’s mission is to democratize healthcare globally and help all patients get better faster. For more information visit www.genieMD.com or contact bizdev@genieMD.com
—————————————————————————————————————————-
For more information, please contact Thomas Foley of GenieMD at (925) 460-9191 x707
or tom@GenieMD.com.